Abbott Laboratories (ABT.N)
71.42USD
18 Jan 2019
$0.90 (+1.28%)
$70.52
$70.91
$71.74
$70.78
3,018,980
1,990,673
$74.91
$55.59
ABT.N
About
Buy/Sell
Overall
| Beta: | 1.57 |
| Market Cap(Mil.): | $95,559.38 |
| Shares Outstanding(Mil.): | 1,737.44 |
| Dividend: | 0.26 |
| Yield (%): | 1.93 |
CORRECTED-FOCUS-U.S. regulators snip red tape for medical devices to curb opioid crisis
Nov 9 Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling device to win U.S. approval as a treatment for chronic migraines.
FOCUS-U.S. regulators snip red tape for medical devices to curb opioid crisis
Nov 9 Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling device to win U.S. approval as a treatment for chronic migraines.
UPDATE 2-Abbott, AbbVie settle TriCor marketing case for $25 mln
Oct 26 Abbott Laboratories and AbbVie Inc will pay a total of $25 million to resolve allegations that Abbott paid kickbacks to doctors in exchange for prescribing the cholesterol drug TriCor and promoted the medication for unapproved purposes.
Abbott, AbbVie settle U.S. case over TriCor marketing for $25 mln
Oct 26 Abbott Laboratories and AbbVie Inc will pay $25 million to resolve allegations that Abbott paid kickbacks to doctors in exchange for them prescribing the cholesterol drug TriCor and promoted the medication for unapproved purposes.
AbbVie CFO Chase to retire by mid-year 2019
AbbVie Inc said on Friday that William Chase stepped down as chief financial officer and will retire from the company in mid-2019, and the U.S. drugmaker promoted controller, Robert Michael, to the CFO role.
UPDATE 2-AbbVie CFO Chase to retire by mid-year 2019
Oct 19 AbbVie Inc said on Friday that William Chase stepped down as chief financial officer and will retire from the company in mid-2019, and the U.S. drugmaker promoted controller, Robert Michael, to the CFO role.
Abbott Labs quarterly profit falls on higher tax expense
Abbott Laboratories reported a 6.6 percent drop in quarterly profit on Wednesday, hurt by higher tax expense on earnings.
UPDATE 1-Abbott Labs quarterly profit falls on higher tax expense
Oct 17 Abbott Laboratories reported a 6.6 percent drop in quarterly profit on Wednesday, hurt by higher tax expense on earnings.
Abbott Labs quarterly profit falls 6.6 pct on tax expense
Oct 17 Diversified healthcare company Abbott Laboratories reported a 6.6 percent drop in quarterly profit on Wednesday, hurt by higher tax expense on earnings.
Märkte
- U.S.
- Europa
- Asien
- Branchen
| DOW | 24,706.35 |
+
336.25 |
+1.38% |
| S&P 500 | 2,670.71 |
+
34.75 |
+1.32% |
| NASDAQ | 7,157.23 | -- | --% |
| TR US Index | 236.47 |
+
3.04 |
+1.30% |
Rohstoffe
| Gold | 1,281.30 | +0.00 | +0.00% |
| Oil | 53.90 | +0.10 | +0.19% |
| Corn | 381.75 | +0.00 | +0.00% |
Rohstoffe
| Gold | 1,281.30 | +0.00 | +0.00% |
| Oil | 53.90 | +0.10 | +0.19% |
| Corn | 381.75 | +0.00 | +0.00% |
Rohstoffe
| Gold | 1,281.30 | +0.00 | +0.00% |
| Oil | 53.90 | +0.10 | +0.19% |
| Corn | 381.75 | +0.00 | +0.00% |
Branchenüberblick
| Energie |
+1.07%
|
| Rohstoffe |
+1.47%
|
| Industrie |
+1.01%
|
| Konjunktur abhängige Waren & Dienstleistungen |
+1.02%
|
| Konjunktur unabhängige Waren & Dienstleistungen |
+1.19%
|
| Finanzindustrie |
+0.97%
|
| Pharma |
+1.31%
|
| Technologie |
+0.57%
|
| Telekommunikation |
+0.30%
|
Nachrichten aus der Wirtschaft
Chinas Konjunkturmotor stottert - Schwächstes Wachstum seit 28 Jahren
Peking Die weltweite Konjunkturlokomotive China verliert an Schwung.